Tysabri approved as Crohn's treatment
January 14 2008
The FDA today approved Elan and Biogen IDEC's supplemental biologics license application for Tysabri to treat Crohn's disease, a chronic ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.